Myeloid Neoplasms
WHO Classification of Hematopoietic & Lymphoid Neoplasms with ICD-O-3 Codes
NOTE: Only major disease categories are listed.
{} indicates an alternative description of the neoplasm
Myelodysplastic/myeloproliferative diseases
ICD-O-3 |
WHO Term |
9945/3 |
Chronic myelomonocytic leukemia |
9876/3 |
Atypical chronic myelogenous leukemia |
9946/3 |
Juvenile myelomonocytic leukemia |
Myelodysplastic syndromes
ICD-O-3 |
WHO Term |
9980/3 |
Refractory anemia |
9982/3 |
With ringed sideroblasts |
9980/3 |
Without ringed sideroblasts |
9985/3 |
Refractory cytopenia (myelodysplastic syndrome) with multilineaage dysplasia |
9983/3 |
Refractory anemia (myelodysplastic syndrome) with excess blasts |
9986/3 |
5q- (5q deletion) syndrome |
9989/3 |
Myelodysplastic syndrome, unclassifiable |
Acute myeloid leukemias (AMLs)
ICD-O-3 |
WHO Term |
|
AMLs with recurrent cytogenetic translacations |
9896/3 |
AML with {t(8;21)(q22;q22)}, {AML1(CBF-alpha)/ETO} |
9866/3 |
Acute promyelocytic leukemia {AML with with t(15;17)
(q22;q11-12} and variants, {PML/RAR-alpha} |
9871/3 |
AML with abnormal bone marrow eosinophils {inv(16) (p13q22)} or {t(16;16)(p13;q11)}, {CBFb/MYH11} |
9897/3 |
AML with 11q23 abnormalities {MLL} |
9895/3 |
AML with multilineage dysplasia |
9895/3 |
With prior myelodysplasic syndrome |
9895/3 |
Without prior myelodysplastic syndrome |
9920/3 |
AML and myelodysplastic syndromes, therapy-related |
9920/3 |
Alkylating agent-related |
9920/3 |
Epipodophyllotoxin-related (some may be lymphoid) |
9920/3 |
Other types |
9861/3 |
AML not otherwise categoriezed |
9872/3 |
AML minimally differentiated |
9873/3 |
AML without maturation |
9874/3 |
AML with maturation |
9867/3 |
Acute myelomonocytic leukemia |
9891/3 |
Acute monocytic leukemia |
9840/3 |
Acute erythroid leukemia |
9910/3 |
Acute megakaryocytic leukemia |
9870/3 |
Acute basophilic leukemia |
9931/3 |
Acute panmyelosis with myelofibrosis |
9805/3 |
Acute biphenotypic leukemias |